Global Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Global Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR748
  • |
  • Pages: 290
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Nasal sprays are the devices that help in delivery of drugs through nose in nasal cavity to treat allergy and other problems related to brain inflammation, diabetes, dental problems, central nervous system. Allergy is a condition in which immune system of the body reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients. There are different types of nasal sprays available in market such as decongestion nasal spray, saline nasal spray and steroid nasal spray. Decongestants are used to treat nasal congestion which provides short-term relief for a blocked or stuffy nose. Decongestion nasal spray comprising of drugs which shrinks the swollen membranes and opens up the airway of the nasal part which makes the breathing process easier.

Global Nasal Spray Market is expected to reach with the CAGR of 6.3% in the forecast period of 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation:

By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care), Geography (Europe, North America, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In product type, decongestion nasal spray segment is expected to dominate the global nasal spray market due to the rising problems associated with the decongestion of conditions such as cold & flu, fever, allergic reactions and sinusitis are helping the segment to grow in the forecast period of 2018 to 2025.

In therapeutic class, antihistamine segment is expected to dominate the market due to rising antihistamine usage amongst population from different diseases such as congestion, runny nose, sneezing, itching, nasal swelling and different products availability by the companies is expected to dominate the market, whereas nasal steroids are available for both prescription and over the counter usage, and fast effective results are the major growth factors of the market.

In container design, pump bottles segment is expected to dominate the market due to the user friendly and wide offering of the over the counter products by the companies and it is expected to fuel the growth of pump bottles market in the forecast period. However, new advancement associated with the pressurized canisters.

The key market players for global nasal spray market are listed below:

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 21

1.1 OBJECTIVES OF THE STUDY 21

1.2 MARKET DEFINITION 21

1.3 OVERVIEW OF NASAL SPRAY MARKET 22

1.4 CURRENCY AND PRICING 23

1.5 LIMITATION 23

1.6 MARKETS COVERED 23

2 MARKET SEGMENTATION 26

2.1 MARKETS COVERED 26

2.2 GEOGRAPHIC SCOPE 27

2.3 YEARS CONSIDERED FOR THE STUDY 28

2.4 CURRENCY AND PRICING 28

2.5 RESEARCH METHODOLOGY 29

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32

2.7 SECONDARY SOURCES 33

2.8 ASSUMPTIONS 33

3 MARKET OVERVIEW 34

3.1 DRIVERS 36

3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 36

3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 37

3.1.3 INCREASE IN INFECTION & ALLERGIC CASES 38

3.2 RESTRAINTS 38

3.2.1 PRODUCT RECALLS 38

3.3 OPPORTUNITIES 39

3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY 39

3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 39

3.4 CHALLENGES 40

3.4.1 REGULATORY HURDLES 40

4 EXECUTIVE SUMMARY 41

5 PREMIUM INSIGHTS 45

?

6 GLOBAL NASAL SPRAY MARKET, BY PRODUCT TYPE 48

6.1 OVERVIEW 49

6.2 DECONGESTION NASAL SPRAY 51

6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY 52

6.4 STEROID NASAL SPRAY 54

6.5 OTHERS 55

7 GLOBAL N ASAL SPRAY MARKET, BY CONTAINER DESIGN 56

7.1 OVERVIEW 57

7.2 PRESSURIZED CANISTERS 59

7.3 PUMP BOTTLES 60

8 GLOBAL NASAL SPRAY MARKET, BY DOSAGE FORM 61

8.1 OVERVIEW 62

8.2 UNIT/SINGLE DOSE 64

8.3 BI DOSE 66

8.4 MULTI DOSE 67

9 GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 69

9.1 OVERVIEW 70

9.2 ANTIHISTAMINE 72

9.3 NASAL STEROIDS 74

9.4 MAST CELL INHIBITOR 75

9.5 ANTICHOLINERGIC 76

10 GLOBAL NASAL SPRAY MARKET, BY APPLICATION 77

10.1 OVERVIEW 78

10.2 ALLERGIC AND NON-ALLERGIC RHINITIS 80

10.3 NASAL CONGESTION 82

10.4 CENTRAL NERVOUS SYSTEM DISORDERS 83

10.5 VACCINATION 84

10.6 OTHERS 85

11 GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION MODE 86

11.1 OVERVIEW 87

11.2 PRESCRIPTION BASED 89

11.3 OVER THE COUNTER 90

?

12 GLOBAL NASAL SPRAY MARKET, BY END USER 92

12.1 OVERVIEW 93

12.2 HOSPITALS 95

12.3 CLINICS 96

12.4 HOME CARE SETTINGS 97

12.5 COMMUNITY HEALTH CARE 98

13 GLOBAL NASAL SPRAY MARKET, BY GEOGRAPHY 99

13.1 OVERVIEW 100

13.2 NORTH AMERICA 105

13.2.1 INCREASING MANUFACTURING CAPABILITIES IN U.S. 105

13.2.2 U.S. 113

13.2.3 CANADA 117

13.2.4 MEXICO 121

13.3 EUROPE 125

13.3.1 STRICT GOVERNMENT REGULATIONS 125

13.3.2 GERMANY 134

13.3.3 U.K. 138

13.3.4 FRANCE 142

13.3.5 ITALY 146

13.3.6 SPAIN 150

13.3.7 SWITZERLAND 154

13.3.8 NETHERLANDS 158

13.3.9 BELGIUM 162

13.3.10 RUSSIA 166

13.3.11 TURKEY 170

13.3.12 REST OF EUROPE 174

13.4 ASIA-PACIFIC 175

13.4.1 INCREAISNG PREVELENCE OF THE COPD 175

13.4.2 CHINA 184

13.4.3 JAPAN 188

13.4.4 INDIA 192

13.4.5 AUSTRALIA 196

13.4.6 SOUTH KOREA 200

13.4.7 MALAYSIA 204

13.4.8 THAILAND 208

13.4.9 SINGAPORE 212

13.4.10 INDONESIA 216

13.4.11 PHILIPPINES 220

13.4.12 REST OF ASIA PACIFIC 224

13.5 SOUTH AMERICA 225

13.5.1 RISING PREVELANCE OF THE NASAL ALLERGIES IN THE LATIN AMERICA 225

13.5.2 BRAZIL 233

13.5.3 REST OF SOUTH AMERICA 237

13.6 MIDDLE EAST AND AFRICA 238

13.6.1 GROWING PREFERENCES FOR DRUG ADMINISTRATION THROUGH INTRA NASAL ROUTE 238

13.6.2 SOUTH AFRICA 246

13.6.3 REST OF MIDDLE EAST & AFRICA 250

14 GLOBAL NASAL SPRAY MARKET, COMPANY LANDSCAPE 251

14.1 COMPANY SHARE ANALYSIS: GLOBAL 251

14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 252

14.3 COMPANY SHARE ANALYSIS: EUROPE 253

14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 254

15 COMPANY PROFILE 255

15.1 PFIZER INC. 255

15.1.1 COMPANY OVERVIEW 255

15.1.2 REVENUE ANALYSIS 255

15.1.3 COMPANY SHARE ANALYSIS 256

15.1.4 PRODUCT PORTFOLIO 257

15.1.5 RECENT DEVELOPMENTS 257

15.2 CIPLA INC. 258

15.2.1 COMPANY OVERVIEW 258

15.2.2 REVENUE ANALYSIS 258

15.2.3 COMPANY SHARE ANALYSIS 259

15.2.4 PRODUCT PORTFOLIO 259

15.2.5 RECENT DEVELOPMENTS 260

15.3 BAYER AG 261

15.3.1 COMPANY OVERVIEW 261

15.3.2 REVENUE ANALYSIS 261

15.3.3 COMPANY SHARE ANALYSIS 262

15.3.4 PRODUCT PORTFOLIO 262

15.3.5 RECENT DEVELOPMENTS 262

15.4 INNOVUS PHARMACEUTICALS, INC. 263

15.4.1 COMPANY OVERVIEW 263

15.4.2 REVENUE ANALYSIS 263

15.4.3 COMPANY SHARE ANALYSIS 264

15.4.4 PRODUCT PORTFOLIO 264

15.4.5 RECENT DEVELOPMENTS 264

15.5 GLAXOSMITHKLINE PLC. 265

15.5.1 COMPANY OVERVIEW 265

15.5.2 REVENUE ANALYSIS 265

15.5.3 PRODUCT PORTFOLIO 266

15.5.4 RECENT DEVELOPMENTS 266

15.6 ADAPT PHARMA, INC. 267

15.6.1 COMPANY OVERVIEW 267

15.6.2 GEOGRAPHIC PRESENCE 267

15.6.3 PRODUCT PORTFOLIO 268

15.6.4 RECENT DEVELOPMENTS 268

15.7 AISHWARYA GROUP 269

15.7.1 COMPANY OVERVIEW 269

15.7.2 PRODUCT PORTFOLIO 269

15.7.3 RECENT DEVELOPMENTS 269

15.8 ALLERGAN 270

15.8.1 COMPANY OVERVIEW 270

15.8.2 REVENUE ANALYSIS 270

15.8.3 PRODUCT PORTFOLIO 270

15.8.4 RECENT DEVELOPMENTS 271

15.9 ARIUS FORMULATIONS PVT LTD 272

15.9.1 COMPANY OVERVIEW 272

15.9.2 PRODUCT PORTFOLIO 272

15.9.3 RECENT DEVELOPMENTS 272

15.10 AURENA 273

15.10.1 COMPANY OVERVIEW 273

15.10.2 GEOGRAPHIC PRESENCE 273

15.10.3 PRODUCT PORTFOLIO 274

15.10.4 RECENT DEVELOPMENTS 274

15.11 CATALENT, INC 275

15.11.1 COMPANY OVERVIEW 275

15.11.2 REVENUE ANALYSIS 275

15.11.3 PRODUCT PORTFOLIO 276

15.11.4 RECENT DEVELOPMENTS 276

15.12 EGALET CORPORATION 277

15.12.1 COMPANY OVERVIEW 277

15.12.2 REVENUE ANALYSIS 277

15.12.3 PRODUCT PORTFOLIO 278

15.12.4 RECENT DEVELOPMENTS 278

?

15.13 J PHARMACEUTICALS 279

15.13.1 COMPANY OVERVIEW 279

15.13.2 PRODUCT PORTFOLIO 279

15.13.3 RECENT DEVELOPMENTS 279

15.14 LEEFORD HEALTHCARE LTD 280

15.14.1 COMPANY OVERVIEW 280

15.14.2 GEOGRAPHIC PRESENCE 280

15.14.3 PRODUCT PORTFOLIO 281

15.14.4 RECENT DEVELOPMENTS 281

15.15 MYLAN N.V. 282

15.15.1 REVENUE ANALYSIS 282

15.15.2 PRODUCT PORTFOLIO 283

15.15.3 RECENT DEVELOPMENTS 283

15.16 SANDOZ INTERNATIONAL GMBH 284

15.16.1 COMPANY OVERVIEW 284

15.16.2 GEOGRAPHIC PRESENCE 284

15.16.3 PRODUCT PORTFOLIO 285

15.16.4 RECENT DEVELOPMENTS 285

15.17 ST. RENATUS 286

15.17.1 COMPANY OVERVIEW 286

15.17.2 PRODUCT PORTFOLIO 286

15.17.3 RECENT DEVELOPMENTS 286

15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD. 287

15.18.1 COMPANY OVERVIEW 287

15.18.2 REVENUE ANALYSIS 287

15.18.3 PRODUCT PORTFOLIO 288

15.18.4 RECENT DEVELOPMENTS 288

15.19 ULTRATECH INDIA LIMITED 289

15.19.1 COMPANY OVERVIEW 289

15.19.2 PRODUCT PORTFOLIO 289

15.19.3 RECENT DEVELOPMENTS 289

16 RELATED REPORTS 290

?

LIST OF FIGURES

FIGURE 1 GLOBAL NASAL SPRAY MARKET: SEGMENTATION 26

FIGURE 2 GLOBAL NASAL SPRAY MARKET: DATA TRIANGULATION 29

FIGURE 3 GLOBAL NASAL SPRAY MARKET: RESEARCH SNAPSHOT 30

FIGURE 4 GLOBAL NASAL SPRAY MARKET:BOTTOM UP APPROACH 31

FIGURE 5 GLOBAL NASAL SPRAY MARKET:TOP DOWN APPROACH 31

FIGURE 6 GLOBALNASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS 32

FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NASAL SPRAY MARKET 35

FIGURE 8 GLOBAL NASAL SPRAY MARKET: SEGMENTATION 43

FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NASAL SPRAY MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 44

FIGURE 10 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025 45

FIGURE 11 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025 46

FIGURE 12 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR NASAL SPRAY MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 47

FIGURE 13 GLOBAL NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017 49

FIGURE 14 GLOBAL NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017 57

FIGURE 15 GLOBAL NASAL SPRAY MARKET: BY DOSAGE FORM, 2017 62

FIGURE 16 GLOBAL NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017 70

FIGURE 17 GLOBAL NASAL SPRAY MARKET: BY APPLICATION, 2017 78

FIGURE 18 GLOBAL NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017 87

FIGURE 19 GLOBAL NASAL SPRAY MARKET: BY END USER, 2017 93

FIGURE 20 GLOBAL NASAL SPRAY MARKET SNAPSHOT (2017) 101

FIGURE 21 GLOBAL NASAL SPRAY MARKET: BY GEOGRAPHY (2017) 102

FIGURE 22 GLOBAL NASAL SPRAY MARKET: BY GEOGRAPHY (2018) 102

FIGURE 23 GLOBAL NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 103

FIGURE 24 GLOBAL NASAL SPRAY MARKET: BY PRODUCT TYPE(2018-2025) 103

FIGURE 25 NORTH AMERICA NASAL SPRAY MARKET SNAPSHOT (2017) 106

FIGURE 26 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017) 107

FIGURE 27 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 107

FIGURE 28 NORTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 108

FIGURE 29 NORTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 108

FIGURE 30 EUROPE NASAL SPRAY MARKET SNAPSHOT (2017) 126

FIGURE 31 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2017) 127

FIGURE 32 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 127

FIGURE 33 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 128

FIGURE 34 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 128

FIGURE 35 ASIA PACIFIC NASAL SPRAY MARKET SNAPSHOT (2017) 176

FIGURE 36 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2017) 177

FIGURE 37 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 177

FIGURE 38 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 178

FIGURE 39 ASIA PACIFIC NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 178

FIGURE 40 SOUTH AMERICA NASAL SPRAY MARKET SNAPSHOT (2017) 226

FIGURE 41 SOUTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017) 227

FIGURE 42 SOUTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 227

FIGURE 43 SOUTH AMERICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 228

FIGURE 44 SOUTH AMERICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 228

FIGURE 45 MIDDLE EAST & AFRICA NASAL SPRAY MARKET SNAPSHOT (2017) 239

FIGURE 46 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017) 240

FIGURE 47 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 240

FIGURE 48 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 241

FIGURE 49 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 241

FIGURE 50 GLOBAL NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 251

FIGURE 51 NORTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 252

FIGURE 52 EUROPE NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 253

FIGURE 53 ASIA-PACIFIC NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 254

LIST OF TABLES

TABLE 1 GLOBAL NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION) 50

TABLE 2 GLOBAL DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 51

TABLE 3 GLOBAL SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 53

TABLE 4 GLOBAL STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 54

TABLE 5 GLOBAL OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 55

TABLE 6 GLOBAL NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION) 58

TABLE 7 GLOBAL PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 59

TABLE 8 GLOBAL PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 60

TABLE 9 GLOBAL NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION) 63

TABLE 10 GLOBAL UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 65

TABLE 11 GLOBAL BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 66

TABLE 12 GLOBAL MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 68

TABLE 13 GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION) 71

TABLE 14 GLOBAL ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 73

TABLE 15 GLOBAL NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 74

TABLE 16 GLOBAL MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 75

TABLE 17 GLOBAL ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 76

TABLE 18 GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION) 79

TABLE 19 GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 81

TABLE 20 GLOBAL NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 82

TABLE 21 GLOBAL CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 83

TABLE 22 GLOBAL VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 84

TABLE 23 GLOBAL OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 85

TABLE 24 GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION) 88

TABLE 25 GLOBAL PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 89

TABLE 26 GLOBAL OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 91

TABLE 27 GLOBAL NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION) 94

TABLE 28 GLOBAL HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 95

TABLE 29 GLOBAL CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 96

TABLE 30 GLOBAL HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 97

TABLE 31 GLOBAL COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 98

TABLE 32 GLOBAL NASAL SPRAY MARKET, BY REGION, 2016-2025 (USD MILLION) 104

TABLE 33 NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025(USD MILLION) 109

TABLE 34 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 109

TABLE 35 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 110

TABLE 36 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 110

TABLE 37 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 111

TABLE 38 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 111

TABLE 39 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 112

TABLE 40 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 112

TABLE 41 U.S. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 113

TABLE 42 U.S. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 113

TABLE 43 U.S. NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 114

TABLE 44 U.S. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 114

TABLE 45 U.S. NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 115

TABLE 46 U.S. NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 115

TABLE 47 U.S. NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 116

TABLE 48 CANADA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 117

TABLE 49 CANADA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 117

TABLE 50 CANADA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 118

TABLE 51 CANADA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 118

TABLE 52 CANADA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 119

TABLE 53 CANADA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 119

TABLE 54 CANADA NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 120

TABLE 55 MEXICO NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 121

TABLE 56 MEXICO NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 121

TABLE 57 MEXICO NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 122

TABLE 58 MEXICO NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 122

TABLE 59 MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 123

TABLE 60 MEXICO NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 123

TABLE 61 MEXICO NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 124

TABLE 62 EUROPEN ASAL SPRAY MARKET, BY COUNTRY, 2016-2025(USD MILLION) 129

TABLE 63 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 130

TABLE 64 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 130

TABLE 65 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 131

TABLE 66 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 131

TABLE 67 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 132

TABLE 68 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 132

TABLE 69 EUROPE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 133

TABLE 70 GERMANY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 134

TABLE 71 GERMANY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 134

TABLE 72 GERMANY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 135

TABLE 73 GERMANY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 135

TABLE 74 GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 136

TABLE 75 GERMANY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 136

TABLE 76 GERMANY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 137

TABLE 77 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 138

TABLE 78 U.K. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 138

TABLE 79 U.K. NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 139

TABLE 80 U.K. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 139

TABLE 81 U.K. NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 140

TABLE 82 U.K. NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 140

TABLE 83 U.K. NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 141

TABLE 84 FRANCE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 142

TABLE 85 FRANCE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 142

TABLE 86 FRANCE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 143

TABLE 87 FRANCE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 143

TABLE 88 FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 144

TABLE 89 FRANCE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 144

TABLE 90 FRANCE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 145

TABLE 91 ITALY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 146

TABLE 92 ITALY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 146

TABLE 93 ITALY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 147

TABLE 94 ITALY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 147

TABLE 95 ITALY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 148

TABLE 96 ITALY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 148

TABLE 97 ITALY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 149

TABLE 98 SPAIN NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 150

TABLE 99 SPAIN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 150

TABLE 100 SPAIN NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 151

TABLE 101 SPAIN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 151

TABLE 102 SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 152

TABLE 103 SPAIN NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 152

TABLE 104 SPAIN NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 153

TABLE 105 SWITZERLAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 154

TABLE 106 SWITZERLAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 154

TABLE 107 SWITZERLAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 155

TABLE 108 SWITZERLAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 155

TABLE 109 SWITZERLAND NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 156

TABLE 110 SWITZERLAND NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 156

TABLE 111 SWITZERLAND NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 157

TABLE 112 NETHERLANDS NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 158

TABLE 113 NETHERLANDS NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 158

TABLE 114 NETHERLANDS NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 159

TABLE 115 NETHERLANDS NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 159

TABLE 116 NETHERLANDS NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 160

TABLE 117 NETHERLANDS NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 160

TABLE 118 NETHERLANDS NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 161

TABLE 119 BELGIUM NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 162

TABLE 120 BELGIUM NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 162

TABLE 121 BELGIUM NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 163

TABLE 122 BELGIUM NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 163

TABLE 123 BELGIUM NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 164

TABLE 124 BELGIUM NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 164

TABLE 125 BELGIUM NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 165

TABLE 126 RUSSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 166

TABLE 127 RUSSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 166

TABLE 128 RUSSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 167

TABLE 129 RUSSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 167

TABLE 130 RUSSIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 168

TABLE 131 RUSSIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 168

TABLE 132 RUSSIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 169

TABLE 133 TURKEY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 170

TABLE 134 TURKEY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 170

TABLE 135 TURKEY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 171

TABLE 136 TURKEY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 171

TABLE 137 TURKEY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 172

TABLE 138 TURKEY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 172

TABLE 139 TURKEY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 173

TABLE 140 REST OF EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 174

TABLE 141 ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2016-2025, (USD MILLION) 179

TABLE 142 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 180

TABLE 143 ASIA-PACIFIC NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 180

TABLE 144 ASIA-PACIFIC NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 181

TABLE 145 ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 181

TABLE 146 ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 182

TABLE 147 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 182

TABLE 148 ASIA-PACIFIC NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 183

TABLE 149 CHINA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 184

TABLE 150 CHINA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 184

TABLE 151 CHINA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 185

TABLE 152 CHINA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 185

TABLE 153 CHINA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 186

TABLE 154 CHINA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 186

TABLE 155 CHINA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 187

TABLE 156 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 188

TABLE 157 JAPAN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 188

TABLE 158 JAPAN NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 189

TABLE 159 JAPAN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 189

TABLE 160 JAPAN NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 190

TABLE 161 JAPAN NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 190

TABLE 162 JAPAN NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 191

TABLE 163 INDIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 192

TABLE 164 INDIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 192

TABLE 165 INDIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 193

TABLE 166 INDIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 193

TABLE 167 INDIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 194

TABLE 168 INDIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 194

TABLE 169 INDIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 195

TABLE 170 AUSTRALIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 196

TABLE 171 AUSTRALIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 196

TABLE 172 AUSTRALIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 197

TABLE 173 AUSTRALIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 197

TABLE 174 AUSTRALIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 198

TABLE 175 AUSTRALIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 198

TABLE 176 AUSTRALIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 199

TABLE 177 SOUTH KOREA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 200

TABLE 178 SOUTH KOREA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 200

TABLE 179 SOUTH KOREA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 201

TABLE 180 SOUTH KOREA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 201

TABLE 181 SOUTH KOREA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 202

TABLE 182 SOUTH KOREA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 202

TABLE 183 SOUTH KOREA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 203

TABLE 184 MALAYSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 204

TABLE 185 MALAYSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 204

TABLE 186 MALAYSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 205

TABLE 187 MALAYSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 205

TABLE 188 MALAYSIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 206

TABLE 189 MALAYSIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 206

TABLE 190 MALAYSIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 207

TABLE 191 THAILAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 208

TABLE 192 THAILAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 208

TABLE 193 THAILAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 209

TABLE 194 THAILAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 209

TABLE 195 THAILAND NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 210

TABLE 196 THAILAND NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 210

TABLE 197 THAILAND NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 211

TABLE 198 SINGAPORE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 212

TABLE 199 SINGAPORE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 212

TABLE 200 SINGAPORE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 213

TABLE 201 SINGAPORE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 213

TABLE 202 SINGAPORE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 214

TABLE 203 SINGAPORE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 214

TABLE 204 SINGAPORE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 215

TABLE 205 INDONESIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 216

TABLE 206 INDONESIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 216

TABLE 207 INDONESIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 217

TABLE 208 INDONESIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 217

TABLE 209 INDONESIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 218

TABLE 210 INDONESIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 218

TABLE 211 INDONESIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 219

TABLE 212 PHILIPPINES NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 220

TABLE 213 PHILIPPINES NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 220

TABLE 214 PHILIPPINES NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 221

TABLE 215 PHILIPPINES NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 221

TABLE 216 PHILIPPINES NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 222

TABLE 217 PHILIPPINES NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 222

TABLE 218 PHILIPPINES NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 223

TABLE 219 REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 224

TABLE 220 SOUTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 229

TABLE 221 SOUTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)T 229

TABLE 222 SOUTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 230

TABLE 223 SOUTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION) 230

TABLE 224 SOUTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 231

TABLE 225 SOUTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 231

TABLE 226 SOUTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 232

TABLE 227 SOUTH AMERICA NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 232

TABLE 228 BRAZIL NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)T 233

TABLE 229 BRAZIL NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025 (USD MILLION) 233

TABLE 230 BRAZIL NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025 (USD MILLION)T 234

TABLE 231 BRAZIL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025 (USD MILLION) 234

TABLE 232 BRAZIL NASAL SPRAY MARKET, BY APPLICATION, 2016-2025 (USD MILLION) 235

TABLE 233 BRAZIL NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025 (USD MILLION) 235

TABLE 234 BRAZIL NASAL SPRAY MARKET, BY END USER, 2016-2025 (USD MILLION) 236

TABLE 235 CANADA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)T 237

TABLE 236 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025, (USD MILLION) 242

TABLE 237 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 242

TABLE 238 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 243

TABLE 239 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 243

TABLE 240 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 244

TABLE 241 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 244

TABLE 242 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 245

TABLE 243 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 245

TABLE 244 SOUTH AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 246

TABLE 245 SOUTH AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 246

TABLE 246 SOUTH AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 247

TABLE 247 SOUTH AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 247

TABLE 248 SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 248

TABLE 249 SOUTH AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 248

TABLE 250 SOUTH AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 249

TABLE 251 REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 250

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group

select a license
Single User License
USD 4200 INR 302064
Corporate User License
USD 5400 INR 388368

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com